MarketPeel
Insider Trading Intelligence
GC

Gabriele M. Cerrone

OKYO
NON-EXECUTIVE CHAIRMAN · OKYO PHARMA LTD · CIK 0001139306
FILING MIX · LIFETIME100%/0%
BUYS
11
SELLS
0
TOTAL VALUE
$2.28M
COMPANIES
2
ACTIVE SINCE
May 2022
HOLDINGS NOW
55,688,503
AVG SELL PX
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Gabriele M. Cerrone, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+0.00%-37.64%+0.27%-37.91%-37.91%
14d4+0.00%-42.86%+4.15%-47.01%-47.01%
30d4+0.00%-37.19%-7.93%-29.26%-29.26%
60d4+0.00%-38.87%-3.39%-35.48%-35.48%
90d4+0.00%-36.78%+7.75%-44.54%-44.54%
180d4+0.00%-36.03%+0.39%-36.41%-36.41%
1y4+0.00%-52.57%+6.36%-58.94%-58.94%
2y4+0.00%-55.77%+36.92%-92.69%-92.69%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OKYO · 10,873,916 shares · as of Jul 21, 2026
0137,245,304274,490,608411,735,911548,981,2152023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 11 buys / 0 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TLSA
TIZIANA LIFE SCIENCES LTD
PURCHASEGRANT
Stock grant
42,357$0.99$41.9K44,814,587Jul 21, 2026Jul 23, 2026View →
OKYO
OKYO PHARMA LTD
PURCHASEGRANT
Stock grant
22,500$1.45$32.6K10,873,916Jul 21, 2026Jul 23, 2026View →
OKYO
OKYO PHARMA LTD
PURCHASEGRANT
Stock grant
25,000$1.40$35.0K10,851,416Jul 20, 2026Jul 21, 2026View →
TLSA
TIZIANA LIFE SCIENCES LTD
PURCHASEGRANT
Stock grant
15,000$1.11$16.6K44,772,230Jun 12, 2026Jun 16, 2026View →
OKYO
OKYO PHARMA LTD
PURCHASEGRANT
Stock grant
300,000$1.72$516.0K10,826,416Jun 8, 2026Jun 10, 2026View →
OKYO
OKYO PHARMA LTD
PURCHASE
Executive Chairman
70,071$1.50$105.1K9,177,903Oct 27, 2023Oct 31, 2023View →
OKYO
OKYO PHARMA LTD
PURCHASE
Executive Chairman
499,468$1.50$749.2K9,107,832Oct 23, 2023Oct 31, 2023View →
OKYO
OKYO PHARMA LTD
PURCHASE
Non-Executive Chairman
37,500$4.00$150.0K62,500May 19, 2022May 19, 2022View →
OKYO
OKYO PHARMA LTD
PURCHASE
Executive Chairman
5,800,000$0.08$440.8K548,981,215May 19, 2022May 20, 2022View →
OKYO
OKYO PHARMA LTD
PURCHASE
Non-Executive Chairman
1,625,000$0.06$96.7K544,806,215May 17, 2022May 18, 2022View →
OKYO
OKYO PHARMA LTD
PURCHASE
Non-Executive Chairman
25,000$3.87$96.8K25,000May 17, 2022May 18, 2022View →
Other insiders · OKYO
Loading peer insiders…
About this filer
CIK 0001139306
ROLE
Non-Executive Chairman
PRIMARY
OKYO
COMPANIES
2
ACTIVE SINCE
May 2022
MARKETPEEL · /INSIDER/0001139306DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback